scispace - formally typeset
R

Roy M. Gabriel

Researcher at Oregon Health & Science University

Publications -  20
Citations -  377

Roy M. Gabriel is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Managed care & Substance abuse. The author has an hindex of 10, co-authored 20 publications receiving 362 citations.

Papers
More filters
Journal ArticleDOI

The toughest job you'll ever love: a Pacific Northwest Treatment Workforce Survey.

TL;DR: Results of the survey indicate that there is an average of 25% turnover per year among treatment agency staff, and that the vast majority of this turnover is voluntary and stays within the treatment profession.
Journal ArticleDOI

Access to substance abuse treatment services under the Oregon Health Plan.

TL;DR: According to analyses, Medicaid-eligible persons in Oregon observed an increase in access to substance abuse treatment after a shift to managed care, and operating characteristics of these prepaid health plans were significant predictors of access.
Journal ArticleDOI

Access barriers to substance abuse treatment for persons with disabilities: an exploratory study.

TL;DR: Using the Behavioral Model for Vulnerable Populations as a research framework, reasons for differences in access to SA treatment for Medicaid-eligible adults with disabilities in Oregon are identified and needed policy and practice changes to increase access rates for PWDs are suggested.
Journal ArticleDOI

Organization and Financing of Alcohol and Substance Abuse Programs for American Indians and Alaska Natives

TL;DR: Half of the American Indians and Alaska Natives treated for substance abuse were served by programs apparently unaffiliated with the IHS or tribal governments, and Medicaid participation by tribal programs was not universal.
Journal ArticleDOI

Outcomes for medicaid clients with substance abuse problems before and after managed care

TL;DR: Outcome measures were retention in treatment for 90 days or more, completion of a treatment program, abstinence at discharge, and readmission to treatment, and with the exception of readmission, there were no notable differences in outcomes between the fee for service era clients versus those in capitated chemical dependency treatment.